Health Care Cost

The FDA approved a supplemental BLA for Organon's tocilizumab biosimilar Tofidence.

New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages.

Learn how payer fee schedules impact practices, curb administrative costs in healthcare, and boost revenue with audits, tech, and smarter contracts.

Data alone can’t cut health care costs. Pairing predictive analytics with nurse-led care management drives true patient engagement.

Covering delgocitinib for chronic hand eczema could save a 1M-member plan $88M over 3 years, driven by lower drug costs than off-label therapies.

Cancer trauma, drug pricing claims, abortion cost gaps, insurance denials affecting 1 in 5, and food insecurity's economic toll top this week's roundup.

Veterans with Alzheimer disease (AD), identified using clinical notes, have higher health care utilization than veterans without AD.

During a White House briefing, Mehmet Oz, MD, discussed the expansion of Trump Rx and crackdowns on duplicate ACA enrollment and fraudulent hospice programs.

The problem is not that price transparency itself has failed, but rather that policy makers have focused their efforts on the wrong place.

Coverage denials delay care, drive patients into debt, and erode trust in insurers—yet nearly half of affected patients never appeal.

Even spending just 5% of income on medical costs raises food insecurity risk by 80% for families with children, study finds.

New CMS Medicaid work requirements could increase employment but may also cause millions of adults to lose coverage by 2027.

Abortion costs and Medicaid coverage vary by state, creating financial barriers for patients seeking care after the Dobbs v Jackson decision.

Accountable care offers one of the most promising frameworks for stabilizing and expanding access, but only if policy is intentionally designed to support rural participation.

Food insecurity among working-age US adults has significant economic consequences, primarily driven by increased job instability and income insecurity.

Reports highlight gaps in private equity oversight, MA vs FFS outcomes, cancer care access advances, climate health disparities, and uneven genomic testing.

A reproducible Prior Authorization Friction Index enables payers to identify glucagon-like peptide-1 delays and rework, reduce avoidable barriers, and monitor utilization, budgets, and equity in real-world practice.

Despite high US health care spending, data show lower life expectancy, worse maternal mortality, and too few primary care doctors.

Medicare FFS beneficiaries with metastatic cancer received broad genomic profiling more often than MA patients.

Discussions highlighted implementing innovative treatments and ensuring patients treated in the community setting have equitable access to advanced therapeutics.

Private equity reshapes care—new evidence links staffing cuts to patient safety risks; ACP urges regulatory oversight to defend clinical autonomy.

Insured patients paying over $15 in generic drug co-pays may save more buying direct through a direct-to-consumer pharmacy like Cost Plus Drugs

US health care faces massive shifts: rising ACA deductibles, federal health leadership shakeups, and major care gaps in women's health and dermatology.

New review details biologic, psychosocial, and treatment barriers shaping outcomes in AYA acute lymphoblastic leukemia (ALL).

Three hospital systems claim CVS Health secretly pocketed 340B savings meant for indigent care.